Phase I and pharmacokinetic study of HGS-ETR2, a human monoclonal antibody to TRAIL R2, in patients with advanced solid malignanciesSimon Pacey, Johann S. de Bono, Sarah P. Blagden et al.|Journal of Clinical Oncology|2005Cited by 22